HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases.

AbstractAIM:
To assess if a specific cytotoxic T cell response can be induced in patients with malignant liver tumors treated with radio-frequency ablation (RFA).
METHODS:
Six Patients with liver metastases of colorectal cancer and 6 with hepatocellular carcinoma (HCC) underwent RFA. Blood was sampled before, 4 and 8 wk after RFA. Test antigens were autologous liver and tumor lysate obtained from each patient by biopsy. Peripheral T cell activation was assessed by an interferon gamma (IFNgamma) secretion assay and flow cytometry. T cells were double-stained for CD4/CD8 and IFNgamma to detect cytotoxic T cells. The ratio of IFNgamma positive and IFNgamma negative T cells was determined as the stimulation index (SI). To assess cytolytic activity, T cells were co-incubated with human CaCo colorectal cancer and HepG2 HCC cells and release of cytosolic adenylate kinase was measured by a luciferase assay.
RESULTS:
Before RFA SI was 0.021 (+/- 0.006) for CD4(+) and 0.022 (+/- 0.004) for CD8(+) T cells against nonmalignant liver tissue and 0.018 (+/- 0.005) for CD4(+) and 0.021 (+/- 0.004) for CD8(+) cells against autologous tumor tissue. Four weeks after RFA SI against tumor tissue increased to 0.109 (+/- 0.005) for CD4(+) and 0.11 (+/- 0.012) for CD8(+) T cells against HCC, and to 0.115 (+/- 0.031) for CD4(+) and 0.15 (+/- 0.02) for CD8(+) cells for colorectal metastases (P < 0.0001). No increased SI was observed with nonmalignant tumor tissue at all time points. Before RFA cytolytic activity against the respective cancer cells was low with 2.62 (+/- 0.37) relative luminescence units (RLU), but rose more than 100 fold 4 and 8 wk after RFA. Spontaneous release was < 2% of maximum release in all experiments.
CONCLUSION:
Patients with primary and secondary tumors of the liver show a significant tumor-specific cytotoxic T-cell stimulation with a dramatically increased tumor specific cytolytic activity of CD8(+) T cells after RFA.
AuthorsJohannes Hansler, Thaddaus-Till Wissniowski, Detlef Schuppan, Astrid Witte, Thomas Bernatik, Eckhart-Georg Hahn, Deike Strobel
JournalWorld journal of gastroenterology (World J Gastroenterol) Vol. 12 Issue 23 Pg. 3716-21 (Jun 21 2006) ISSN: 1007-9327 [Print] United States
PMID16773688 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interferon-gamma
  • Adenylate Kinase
Topics
  • Adenylate Kinase (analysis)
  • Aged
  • Aged, 80 and over
  • CD4-Positive T-Lymphocytes (chemistry, physiology)
  • CD8-Positive T-Lymphocytes (chemistry, physiology)
  • Carcinoma, Hepatocellular (immunology, surgery)
  • Catheter Ablation
  • Coculture Techniques
  • Colorectal Neoplasms (pathology, surgery)
  • Female
  • Humans
  • Interferon-gamma (analysis, physiology)
  • Liver Neoplasms (immunology, secondary, surgery)
  • Lymphocyte Activation (physiology)
  • Male
  • Middle Aged
  • Necrosis (pathology)
  • Neoplasm Metastasis (pathology, physiopathology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: